SELLAS Life Sciences (SLS) Non-Current Debt (2013 - 2018)

SELLAS Life Sciences (SLS) has 5 years of Non-Current Debt data on file, last reported at $1.2 million in Q1 2018.

• Non-Current Debt for Q1 2018 came in at $1.2 million, changed N/A year-over-year; the trailing twelve-month figure through Mar 2018 was $1.2 million (changed N/A YoY), and the FY2017 annual result was $2.6 million, changed N/A from the prior year.
• Non-Current Debt eased to $1.2 million in Q1 2018 per SLS's latest filing, from $2.6 million in the prior quarter.
• Over five years, Non-Current Debt peaked at $6.9 million in Q1 2014 and troughed at $1.2 million in Q1 2018.
• A 4-year average of $3.8 million and a median of $3.5 million in 2015 frame the typical range for Non-Current Debt.
• The sharpest annual moves came in 2014 and 2015: Non-Current Debt tumbled 36.16% in 2014, then tumbled 70.06% in 2015.
• A 4-year view of Non-Current Debt shows it stood at $4.5 million in 2014, then slumped by 66.03% to $1.5 million in 2015, then surged by 71.1% to $2.6 million in 2017, then plunged by 55.96% to $1.2 million in 2018.
• Business Quant data shows SLS's Non-Current Debt at $1.2 million in Q1 2018, $2.6 million in Q4 2017, and $1.5 million in Q3 2015.